Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2013
05/22/2013CN102134214B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
05/22/2013CN102127030B 4-(substituted-1,3-dialkynyl)-4-(trifluoromethyl)benzo-1,4-dihydroxazole-2-one compounds and preparation method and applications thereof
05/22/2013CN101687786B Hydroxylamine compounds and methods of their use
05/22/2013CN101479250B Tetrazole-substituted arylamides
05/21/2013US8445694 Hydrazonopyrazole derivatives and their use as therapeutics
05/21/2013US8445692 Compounds that inhibit (block) bitter taste in composition and use thereof
05/21/2013US8445684 Nicotinic acetylcholine receptor ligands and the uses thereof
05/21/2013US8445683 Porphyrin compounds comprising one or more pyridone moieties
05/21/2013US8445675 Storage stable perfusion solution for dihydropteridinones
05/21/2013US8445525 Carboxylic acid amides, the preparation thereof and their use as medicaments
05/21/2013US8445515 C5aR antagonists
05/21/2013US8445489 Aryl ether pyridazinone derivatives
05/21/2013US8445487 Purine PI3K inhibitor compounds and methods of use
05/21/2013US8445486 Triazine compounds as PI3 kinase and mTOR inhibitors
05/21/2013US8445480 CETP inhibitors derived from benzoxazole arylamides
05/21/2013US8445478 Azetidine derivatives, their preparation and their application in therapy
05/21/2013US8445477 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/21/2013US8445407 Herbicidal tetrahydrophthalimides
05/21/2013CA2560162C Inhibitors of iap
05/16/2013WO2013071272A1 Kinase inhibitor polymorphs
05/16/2013WO2013071094A1 Compounds useful as inhibitors of atr kinase
05/16/2013WO2013071093A1 Pyrazine compounds useful as inhibitors of atr kinase
05/16/2013WO2013071090A1 Compounds useful as inhibitors of atr kinase
05/16/2013WO2013071085A1 Pyrazine compounds useful as inhibitors of atr kinase
05/16/2013WO2013070116A2 Novel antithrombotic and antiatherosclerotic agent and method for producing same (variants)
05/16/2013WO2013069765A1 Nitrogenated heterocyclic compound
05/16/2013WO2013068948A1 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
05/16/2013WO2013068935A1 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
05/16/2013WO2013068769A1 Pharmaceutical compounds
05/16/2013WO2013068554A1 New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activities
05/16/2013WO2013068552A1 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING β2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES
05/16/2013WO2013068470A1 Inhibitors of phosphodiesterase type 10a
05/16/2013WO2013067578A1 Modulators of c3a receptors
05/16/2013US20130123494 Complex compound and optical recording medium containing same
05/16/2013US20130123493 Process for the synthesis of substituted urea compounds
05/16/2013US20130123310 Modulators of sperm hypermobility and uses thereof
05/16/2013US20130123284 Heterocyclic compounds useful for kinase inhibition
05/16/2013US20130123260 Methods
05/16/2013US20130123258 4(1H)-Quinolones Having Antimalarial Activity With Reduced Chemical Resistance
05/16/2013US20130123257 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
05/16/2013US20130123253 Modulators of central nervous system neurotransmitters
05/16/2013US20130123252 2,3,5-Trisubstituted Thiophene Compounds and Uses Thereof
05/16/2013US20130123251 Benzoxazine derivatives and uses thereof
05/16/2013US20130123247 Arthropodicidal anthranilamides
05/16/2013US20130123243 Diamine derivatives as inhibitors of leukotriene a4 hydrolase
05/16/2013US20130123241 Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
05/16/2013US20130123230 2-Thiopyrimidinones
05/16/2013US20130123229 CB1 Receptor Antagonists and Uses Thereof
05/16/2013CA2855204A1 Pharmaceutical compounds
05/16/2013CA2854264A1 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
05/16/2013CA2852604A1 Inhibitors of phosphodiesterase type 10a
05/16/2013CA2849872A1 New cyclohexylamine derivatives having .beta.2 adrenergic agonist and m3 muscarinic antagonist activities
05/16/2013CA2849868A1 New cyclohexylamine derivatives having .beta.2 adrenergic agonist and m3 muscarinic antagonist activities
05/16/2013CA2846568A1 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
05/15/2013EP2592079A2 Insecticidal compounds
05/15/2013EP2592078A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
05/15/2013EP2592077A1 New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
05/15/2013EP2592071A1 Tricyclic heterocyclic compounds
05/15/2013EP2592070A2 Tetrazole-substituted arylamides
05/15/2013EP2590970A1 Crystalline form of rivaroxaban dihydrate
05/15/2013EP2590969A2 Therapeutic agents 976
05/15/2013EP2590963A1 (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists
05/15/2013EP2590954A1 Bisaryl (thio)morpholine derivatives as s1p modulators
05/15/2013EP2590953A1 Tetrazole compounds as calcium channel blockers
05/15/2013EP2590950A1 N-cyclyl-3 - (cyclylcarbonylaminomethyl) benzamide derivatives as rho kinase inhibitors
05/15/2013EP2590944A1 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
05/15/2013EP2590655A1 Compounds and methods for inhibiting phosphate transport
05/15/2013CN103108867A Oxadiazole compounds, their preparation and use
05/15/2013CN103108864A Arylosulfonamides for the treatment of cns diseases
05/15/2013CN103102348A Oxadiazole compound and preparation method thereof, medicine composition and application thereof
05/15/2013CN103102342A Aminoquinazoline derivative, salts thereof and application method
05/15/2013CN103102322A Oxazole compound and preparation method thereof, medicine composition and application thereof
05/15/2013CN103102303A Benzylamine derivatives as CETP inhibitors
05/15/2013CN102076671B Triazole derivative or salt thereof
05/15/2013CN101627034B Amino- pyridine derivatives as s1p1 /edg1 receptor agonists
05/14/2013US8440837 2-substituted-ethynylthiazole derivatives and uses of same
05/14/2013US8440702 1,3-oxazolidin -2-one derivatives useful as CETP inhibitors
05/14/2013US8440700 Substituted aryloxazoles and their use
05/14/2013US8440666 Pyridazinone compounds and P2X7 receptor inhibitors
05/14/2013US8440663 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of use
05/14/2013US8440662 Substituted quinazoline and pyrido-pyrimidine derivatives
05/14/2013US8440658 Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
05/14/2013US8440651 Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use
05/14/2013CA2716369C Phenoxypropylamine compounds
05/14/2013CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
05/10/2013WO2013067267A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine
05/10/2013WO2013067264A1 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity
05/10/2013WO2013066869A1 Piperidinyl-substituted lactams as gpr119 modulators
05/10/2013WO2013066839A2 Compounds and methods
05/10/2013WO2013066836A1 Compounds and methods
05/10/2013WO2013066835A2 Compounds and methods
05/10/2013WO2013066833A1 Compounds and methods to inhibit histone deacetylase (hdac) enzymes
05/10/2013WO2013065835A1 Pharmaceutical composition for treating diabetes
05/10/2013WO2013065463A1 Method for producing phenyl-substituted heterocyclic derivative
05/10/2013WO2013064983A1 Benzenesulfonamide compounds and their use as therapeutic agents
05/10/2013WO2013064519A1 Pesticidal compounds
05/10/2013WO2013064465A1 New aryl-quinoline derivatives
05/10/2013WO2013064461A2 Compounds with nematicidal activity
05/10/2013WO2013064231A1 SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
05/10/2013WO2013006308A3 Dihydropyrazoles, pharmaceutical compositions thereof and their use for the treatment of fertility disorders
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 647